CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
There is no consensus on the exact role of the adaptive immune system in Parkinson’s disease pathogenesis, although there is increasing evidence that it is somehow involved. Moreover, T cell infiltration in the brain has not been thoroughly studied in Parkinson’s disease and no study has assessed the infiltration in incidental Lewy body diseases cases that are considered to be early presymptomatic stages of the disease. In this study, we performed an immunohistochemistry/immunofluorescence quantitative and phenotypic assessment of T cell infiltration in human substantia nigra pars compacta and analysed the correlations with neuronal death and synucleinopathy throughout different stages of the disease. We included two groups of incidental Lewy disease in the study. One of the groups, which is believed to be the earliest stage of the disease, showed α-synuclein aggregates only in the olfactory bulb. The second group also presented α-synuclein aggregates in the substantia nigra. We also assessed the formation of different α-synuclein aggregates throughout the different stages of the unified staging system for Lewy body disorders (I to IV). We found that CD8 T cells were increased in diagnosed Parkinson’s disease cases compared to the control group and their density positively correlated with neuronal death. Some of the infiltrating CD8 T cells were indeed contacting dopaminergic neurons. No differences were found regarding CD4 T cells. In the earliest stage of the disease, when substantia nigra α-synuclein aggregation is absent, we found a robust CD8 T cell infiltration and no dopaminergic neuronal death yet. Conversely, in the next stage we found neuronal loss and a milder CD8 T cell infiltration. CD8 T cell infiltration paralleled that of α-synuclein accumulation and neuronal death throughout stages II to IV. We also confirmed that CD8 T cells in charge of immune surveillance and involved in the aetiopathogenesis of the disease are equipped with cytolytic enzymes (granzyme A, B and K) and/or proinflammatory cytokines (interferon gamma), and that phenotypic differences were observed between early and late stages of the disease. We also demonstrate that a high proportion of nigral CD8 T cells are tissue resident memory T cells. Our results show that nigral cytotoxic CD8 T cell infiltration is an earlier pathogenic event than α-synuclein aggregation and neuronal death and that it parallels the progression of neuronal death and synucleinopathy in Parkinson’s disease. Overall, our study suggests that CD8 T cell cytotoxic attack may initiate and propagate neuronal death and synucleinopathy in Parkinson’s disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other authors have demonstrated that cytotoxic CD8 + T cell infiltration occurred earlier than a-synuclein aggregation and neuronal death, suggesting adaptive immune system involvement.87”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [87]
Citations
Cites
1 retracted
Chandra, G., Rangasamy, S. B., Roy, A., Kordower, J. H., & Pahan, K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.714824 · Cited by 90
RetractedStaging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Perforin and granzymes: function, dysfunction and human pathology
Voskoboinik, I., Whisstock, J. C., & Trapani, J. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3839 · Cited by 1,327
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K., & Oliveira, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00847 · Cited by 1,224
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
Hamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J., Yearout, D., Kay, D. M., Doheny, K. F., Paschall, J., Pugh, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.642 · Cited by 784
the Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Lue, L., Sue, L. I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Boyer, S., Shirohi, S., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0538-8 · Cited by 698
Understanding Dopaminergic Cell Death Pathways in Parkinson Disease
Michel, P. P., Hirsch, E. C., & Hunot, S. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.038 · Cited by 600
Wakim, L. M., Woodward-Davis, A., & Bevan, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010201107 · Cited by 575
Machado-Santos, J., Saji, E., Tröscher, A. R., Paunovic, M., Liblau, R., Gabriely, G., Bien, C. G., Bauer, J., & Lassmann, H. (2018) · Brain · doi:10.1093/brain/awy151 · Cited by 548
Dehay, B., Bourdenx, M., Gorry, P., Przedborski, S., Vila, M., Hunot, S., Singleton, A., Olanow, C. W., Merchant, K. M., Bezard, E., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00006-x · Cited by 529
Self-citationInterferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity
Bhat, P., Leggatt, G., Waterhouse, N., & Frazer, I. H. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.67 · Cited by 515
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease
Reynolds, A. D., Banerjee, R., Liu, J., Gendelman, H. E., & Lee Mosley, R. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507296 · Cited by 420
Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., Cron, R. Q., Shacka, J. J., Raman, C., & Standaert, D. G. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5610-12.2013 · Cited by 406
Tissue-resident memory T cells populate the human brain
Smolders, J., Heutinck, K. M., Fransen, N. L., Remmerswaal, E. B. M., Hombrink, P., ten Berge, I. J. M., van Lier, R. A. W., Huitinga, I., & Hamann, J. (2018) · Nature Communications · doi:10.1038/s41467-018-07053-9 · Cited by 406
Braak, H., & Del Tredici, K. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-179001 · Cited by 372
Theodore, S., Cao, S., McLean, P. J., & Standaert, D. G. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818e5e99 · Cited by 367
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease
Dickson, D. W., Fujishiro, H., DelleDonne, A., Menke, J., Ahmed, Z., Klos, K. J., Josephs, K. A., Frigerio, R., Burnett, M., Parisi, J. E., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0345-7 · Cited by 364
Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
Benner, E. J., Banerjee, R., Reynolds, A. D., Sherman, S., Pisarev, V. M., Tsiperson, V., Nemachek, C., Ciborowski, P., Przedborski, S., Mosley, R. L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001376 · Cited by 362
Genome-wide pleiotropy between Parkinson disease and autoimmune diseases
Witoelar, A., Jansen, I. E., Wang, Y., Desikan, R. S., Gibbs, J. R., Blauwendraat, C., Thompson, W. K., Hernandez, D. G., Djurovic, S., Schork, A. J., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0469 · Cited by 352
Cell Death Mechanisms Induced by Cytotoxic Lymphocytes
Chávez-Galán, L., Arenas-Del Angel, M. C., Zenteno, E., Chávez, R., & Lascurain, R. (2009) · Cellular & Molecular Immunology · doi:10.1038/cmi.2009.3 · Cited by 349
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
Cebrián, C., Zucca, F. A., Mauri, P., Steinbeck, J. A., Studer, L., Scherzer, C. R., Kanter, E., Budhu, S., Mandelbaum, J., Vonsattel, J. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4633 · Cited by 338
Alterations of T-lymphocyte populations in Parkinson disease
Baba, Y., Kuroiwa, A., Uitti, R. J., Wszolek, Z. K., & Yamada, T. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.07.005 · Cited by 336
CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease
Saunders, J. A. H., Estes, K. A., Kosloski, L. M., Allen, H. E., Dempsey, K. M., Torres-Russotto, D. R., Meza, J. L., Santamaria, P. M., Bertoni, J. M., Murman, D. L., et al. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9402-z · Cited by 323
Mechanisms and dynamics of T cell-mediated cytotoxicity in vivo
Halle, S., Halle, O., & Förster, R. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.04.002 · Cited by 302
Kustrimovic, N., Comi, C., Magistrelli, L., Rasini, E., Legnaro, M., Bombelli, R., Aleksic, I., Blandini, F., Minafra, B., Riboldazzi, G., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1248-8 · Cited by 278
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases
Espay, A. J., Vizcarra, J. A., Marsili, L., Lang, A. E., Simon, D. K., Merola, A., Josephs, K. A., Fasano, A., Morgante, F., Savica, R., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000006926 · Cited by 274
Sanchez-Guajardo, V., Febbraro, F., Kirik, D., & Romero-Ramos, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008784 · Cited by 256
Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism
Bas, J. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00422-7 · Cited by 250
Cytotoxic and non‐cytotoxic roles of the CTL/NK protease granzyme B
Afonina, I. S., Cullen, S. P., & Martin, S. J. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00908.x · Cited by 247
Role of α-Synuclein in Inducing Innate and Adaptive Immunity in Parkinson Disease
Allen Reish, H. E., & Standaert, D. G. (2015) · Journal of Parkinson’s Disease · doi:10.3233/jpd-140491 · Cited by 244
Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders
The Arizona Parkinson’s Disease Consortium, Beach, T. G., White, C. L., Hladik, C. L., Sabbagh, M. N., Connor, D. J., Shill, H. A., Sue, L. I., Sasse, J., Bachalakuri, J., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0450-7 · Cited by 235
Halle, S., Keyser, K. A., Stahl, F. R., Busche, A., Marquardt, A., Zheng, X., Galla, M., Heissmeyer, V., Heller, K., Boelter, J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.010 · Cited by 224
Brain-resident memory T cells represent an autonomous cytotoxic barrier to viral infection
Steinbach, K., Vincenti, I., Kreutzfeldt, M., Page, N., Muschaweckh, A., Wagner, I., Drexler, I., Pinschewer, D., Korn, T., & Merkler, D. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151916 · Cited by 213
Zhang, L., Dermawan, K., Jin, M., Liu, R., Zheng, H., Xu, L., Zhang, Y., Cai, Y., Chu, Y., & Xiong, S. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.07.013 · Cited by 209
The identification of mitochondrial DNA variants in glioblastoma multiforme
Yeung, K. Y., Dickinson, A., Donoghue, J. F., Polekhina, G., White, S. J., Grammatopoulos, D. K., McKenzie, M., Johns, T. G., & John, J. C. S. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-1 · Cited by 202
Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region
Wissemann, W. T., Hill-Burns, E. M., Zabetian, C. P., Factor, S. A., Patsopoulos, N., Hoglund, B., Holcomb, C., Donahue, R. J., Thomson, G., Erlich, H., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.10.009 · Cited by 189
Reduced T helper and B lymphocytes in Parkinson's disease
Stevens, C. H., Rowe, D., Morel-Kopp, M.-C., Orr, C., Russell, T., Ranola, M., Ward, C., & Halliday, G. M. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.015 · Cited by 189
Tissue-Resident Memory CD8+ T Cells: From Phenotype to Function
Topham, D. J., & Reilly, E. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00515 · Cited by 187
α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration
Harms, A. S., Delic, V., Thome, A. D., Bryant, N., Liu, Z., Chandra, S., Jurkuvenaite, A., & West, A. B. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0494-9 · Cited by 181
Immune system responses in Parkinson's disease: Early and dynamic
Tansey, M. G., & Romero‐Ramos, M. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14290 · Cited by 178
Inflammation, Infectious Triggers, and Parkinson's Disease
Caggiu, E., Arru, G., Hosseini, S., Niegowska, M., Sechi, G., Zarbo, I. R., & Sechi, L. A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00122 · Cited by 177
Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas
Plate, J. M. D., Plate, A. E., Shott, S., Bograd, S., & Harris, J. E. (2005) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0638-1 · Cited by 176
Tao, C., Simpson, S., Taylor, B. V., Blizzard, L., Lucas, R. M., Ponsonby, A.-L., Broadley, S., AusLong/Ausimmune Investigators Group, & van der Mei, I. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00418 · Cited by 167
Harari, A., Enders, F. B., Cellerai, C., Bart, P., & Pantaleo, G. (2009) · Journal of Virology · doi:10.1128/jvi.02528-08 · Cited by 164
Fiszer, U., Mix, E., Fredrikson, S., Kostulas, V., & Link, H. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1994.tb02699.x · Cited by 147
Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
Schröder, J. B., Pawlowski, M., Meyer zu Hörste, G., Gross, C. C., Wiendl, H., Meuth, S. G., Ruck, T., & Warnecke, T. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01081 · Cited by 134
Innate and Adaptive Immunity for the Pathobiology of Parkinson's Disease
Stone, D. K., Reynolds, A. D., Mosley, R. L., & Gendelman, H. E. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2460 · Cited by 132
Pey, P., Pearce, R. K., Kalaitzakis, M. E., Griffin, W. S. T., & Gentleman, S. M. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-21 · Cited by 128
Association between Parkinson's disease and the HLA‐DRB1 locus
Ahmed, I., Tamouza, R., Delord, M., Krishnamoorthy, R., Tzourio, C., Mulot, C., Nacfer, M., Lambert, J., Beaune, P., Laurent‐Puig, P., et al. (2012) · Movement Disorders · doi:10.1002/mds.25035 · Cited by 119
Parkinson disease and incidental Lewy body disease: Just a question of time?
Iacono, D., Geraci-Erck, M., Rabin, M. L., Adler, C. H., Serrano, G., Beach, T. G., & Kurlan, R. (2015) · Neurology · doi:10.1212/wnl.0000000000002102 · Cited by 116
Abnormalities of age-related T cell senescence in Parkinson’s disease
Williams-Gray, C. H., Wijeyekoon, R. S., Scott, K. M., Hayat, S., Barker, R. A., & Jones, J. L. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1206-5 · Cited by 97
Cell Death Mechanisms Induced by Cytotoxic Lymphocytes
Chávez-Galán, Arenas-Del, Angel, A., et al. (2009) · 中国免疫学杂志:英文版 · Cited by 69
Signals Controlling Lytic Granule Polarization at the Cytotoxic Immune Synapse
Kabanova, A., Zurli, V., & Baldari, C. T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00307 · Cited by 58
Haile, Y. G., Simmen, K. C., Pasichnyk, D., Touret, N., Simmen, T., Lu, J., Bleackley, R. C., & Giuliani, F. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100943 · Cited by 53
Loeffler, C., Dietz, K., Schleich, A., Schlaszus, H., Stoll, M., Meyermann, R., & Mittelbronn, M. (2011) · Neuropathology · doi:10.1111/j.1440-1789.2010.01167.x · Cited by 49
Davis, S. M., Collier, L. A., Winford, E. D., Leonardo, C. C., Ajmo, C. T., Foran, E. A., Kopper, T. J., Gensel, J. C., & Pennypacker, K. R. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1326-y · Cited by 41
T cells and Parkinson's disease
Mosley, R. L., & Gendelman, H. E. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30276-4 · Cited by 26
Lira, A., Kulczycki, J., Slack, R., Anisman, H., & Park, D. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.244830 · Cited by 25
Research works printed but not linked: 1
- Mosley, 2012, Inflammation and adaptive immunity in Parkinson’s disease. Cold Spring Harb, Perspect Med, 2, 1
Cited by
Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions
Dong-Chen, X., Yong, C., Yang, X., Chen-Yu, S., & Li-Hua, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01353-3 · Cited by 469
“For example, CD4 and CD8 T cells significantly infiltrated into the SN of patients with PD,160 with CD8 T-cell concentrations particularly high.(176,177) Because this infiltration occurs in early-stage PD and subsides with disease progression, CD8 T cells seem to be important at the beginning of the disease.”
BackgroundNeuroinflammation across neurological diseases
Shi, F.-D., & Yong, V. W. (2025) · Science · doi:10.1126/science.adx0043 · Cited by 274
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Blesa, J., Foffani, G., Dehay, B., Bezard, E., & Obeso, J. A. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00542-9 · Cited by 232
Schonhoff, A. M., Figge, D. A., Williams, G. P., Jurkuvenaite, A., Gallups, N. J., Childers, G. M., Webster, J. M., Standaert, D. G., Goldman, J. E., & Harms, A. S. (2023) · Nature Communications · doi:10.1038/s41467-023-39060-w · Cited by 161
“While recent studies have shown a role for CD8 T cells in the neuroinflammatory response to α-syn, their deleterious effects appear to be partially dependent on CD4 function and independent from BAMs[8, 26, 27].”
Metadata
- Authors
- Galiano-Landeira, J., Torra, A., Vila, M., & Bové, J.
- Affiliations
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Corresponding author
- Bové, Jordi
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-10-29
- Volume
- 143
- Issue
- 12
- Pages
- 3717-3733
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W3096763885
- Cited by
- 267
- References
- 62
- Citations by year
- 2026: 43 · 2025: 51 · 2024: 64 · 2023: 46 · 2022: 42 · 2021: 20 · 2020: 1
- FWCI
- 11.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fondo de Investigación Sanitaria-Instituto de Salud Carlos III (PI15/01937, PI18/01894)
- European Union, and Pla Estratègic de Recerca i Innovació en salut-Departament de Salut Generalitat de Catalunya (SLT006/17/00258)
- Ministry of Economy and Competitiveness (SAF2016-77541-R)
- “la Caixa” Foundation (100010434, LCF/PR/HR17/52150003)
- Fondo de Investigación Sanitaria- Instituto de Salud Carlos III
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- CD8+ T cells, T cell infiltration, substantia nigra pars compacta, synucleinopathies, alpha-synuclein aggregation, dopaminergic neuron loss, incidental Lewy body disease, tissue-resident memory T cells, granzymes, interferon-gamma, adaptive immune response, neuroinflammation, cytotoxic T lymphocytes, presymptomatic disease
- MeSH terms
- Synucleinopathies, Aged, Aged, 80 and over, Brain, Cytotoxins, Female, Humans, Immunohistochemistry, Immunologic Surveillance, Male, Neurons, Parkinson Disease, Substantia Nigra, Cytokines, Cell Death, CD8-Positive T-Lymphocytes, Disease Progression, Lewy Body Disease, alpha-Synuclein, Granzymes, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.